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Division of Geographic Medicine, Department of Medicine, Case Western Reserve University and University Hospitals, 
Clevelan.d, Ohio, U.S.A. 
This review summarizes the current evidence that 
both the induction and amelioration of disease in hepa-
to splenic schistosomiasis are immunologically mediated. 
We hypothesize that the extent of disease depends on 
the balance between activation of immunologic disease 
processes and immunologic suppression of disease proc-
esses. In mice the major disease-producing process is 
granuloma formation, a cell-mediated hypersensitivity 
reaction to parasite egg antigens. There appear to be 
multiple possible pathways for the natural suppression 
of this hypersensitivity. Recent work on murine schis-
tosomiasis in our own and other laboratories has de-
tected 3 immunoregulatory systems and has developed 
tools to explore each of them. 
1. Results from serum transfer experiments suggest 
that antibody-mediated immunologic blockade plays a 
role in modulating granuloma formation. Accurate ra-
dioimmunoassays, developed for the quantification of 
, antibody to the major granuloma-producing antigens, 
may be useful in the elucidation of the mechanism of 
blockade. 
. 2 . Cell transfer experiments have demonstrated that 
suppressor T cells can inhibit the cell-mediated immune 
hypersensitivity reaction to schistosome eggs. Lympho-
kine assays, measuring specific suppressor cells may 
enable us to monitor this activity in man. 
3_ Mitogen-induced lymphocyte DNA synthesis is sup-
pressed in chronic schistosomiasis. With this system we 
can examine nonspecific schistosome-induced suppres-
sor cells from persons with schistosomiasis. 
Many of the chronic infections of man, such as tuberculosis, 
fungal infections, and parasite infestations, have clinical and 
pathologic manifestations that appear to be due to hypersensi-
tivity reactions. Nevertheless, when clinical immunologists 
study these conditions they sometimes observe paradoxically 
reduced immunologic reactivity, including failw'e of the dermis 
to respond to ubiquitous antigens, a subnormal response to 
sensitization, or unresponsiveness of leukocytes to antigens 01' 
mitogens. It has often been difficult to know what relation these 
seemingly anomalous immune responses bear to the disease 
state. Are they disease-inducing responses directly responsible 
for disease? Could they be immunoregulatory reactions sup-
pressing the immune responses that cause the disease state? Or 
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are they epiphenomenal responses that have nothing to do with 
induction or amelioration of disease? 
The purpose of this review is to examine the modulation of 
disease-inducing immune responses through use of chronic 
schistosomiasis as a model. We use the word modulation to 
mean that naturally occurring process by which a hypersensi-
tivity reaction is inhibited and the clinical status of an immu-
nologic disease is improved. At present, our knowledge of im-
munoregulation has attained a high degree of sophistication in 
murine model systems. Research on the cellular and molecular 
basis of the response of inbred mice to simple antigens has 
shown that the immune system has an elaborate series of 
checks and baiances. These include: 
1. Immunologic blockade-tlu:ough blocking antibodies or 
immune complexes. 
2. Immunologic unresponsiveness-clonal elimination toler-
ance or the failure of cells to respond to specific antigens. 
3. Suppression-the most recent theory, in which either T 
lymphocytes or macrophages depress the ability of other lym-
phocytes to respond to antigen. 
These immunoregulatory phenomena may be specific to a 
particulal' antigen or nonspecific; if nonspecific, they would 
result in a generalized depression of humoral and/ or cellular 
responses. 
Our knowledge of man's response to chronic infection is 
much less accurate because in man we measure particulal' types 
of immunologic responses at particular points in time, often 
with no knowledge of the actual time of onset of the syndrome. 
We al'e generally dealing with a wide val'iety of complex anti-
gens that may differentially affect the immune response. Many 
of the antigens and responses we study turn out to be irrelevant 
(they are epiphenomena and not centrally related to the disease 
process). When we identify a disease~related immune response, 
it is often impossible to know whether we are dealing with the 
hypersensitivity causing the disease manifestation 01' the im-
munoregulatory response suppressing it. Lastly, one can se-
quester the antigen as disease progresses; sequestration lowers 
the effective dose of antigen reaching the lymphocytes and 
consequently minimjzes stimulation; sequestration can also 
cause persistent stimulation of the immune response long after 
the offending organism has disappeared. Therefore, we must 
view human chronic infect ions not as static entities similar to 
the injection of sheep erythrocytes into a pal·ticular strain of 
inbred mice, but as a dynalTIic and changing set of relationships 
in which a plethora of antigens may both stimulate and suppress 
a variety of host immunologic responses. 
Chronic human disease can . best be studied in appropriate 
animal models that can elucidate the respective response mech-
anisms one by one. The responses of outbred rodents to a 
chronic parasitic infection, schistosomiasis, provides a good 
example of how these various responses can be separated [1]. 
Schistosomiasis affects about 200,000,000 people. This dis-
ease can be studied in outbred mice because the acute and 
chronic pathophysiological changes that occur in human Schis-
tosoma mansoni infection also OCetH in them. Additionally, this 
phenomenon reflects the genetic heterogeneity of the outbred 
human population infected with schistosomiasis. 
Because many people al-e infected but few al'e really sick, om' 
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goal is to answer the question, "What causes significant path-
ologic changes in schistosomiasis?" To answer this question we 
have examined each of the different mechanisms. The process 
can be expressed as: 
00 Disease Disease 
Disease = L Activation - Suppression 
I Processes Processes 
We will consider, consecutively, the mechanisms that have been 
uncovered by starting with the major disease-producing re-
sponse-granuloma formation-and progressively examine dif-
ferent responses that can suppress granulomatous disease. 
DISEASE ACTIVATION 
The Nature of the S chistosome Granuloma. 
Let us fust consider the immunologic stimulus responsible 
for the induction of hepatosplenic disease in schistosomiasis 
[2]. The dynamics of chronic schistosomiasis mansoni are char-
acterized by a low initial antigenic stimulus elicited by the 
schistosomula (young schistosome worms) and adult schisto-
somes; weeks .later this is followed by a relatively massive 
stimulus produced by the daily production of large numbers of 
eggs (egg production may continue for many years) . In the 
murine model of chronic infection, these different immunologic 
responses have marked effects on the pathogenesis of schisto-
somiasis. 
The infective larvae ofthe schistosomes (cercariae) penetrate 
the unbroken skin of the host by way of enzymatic secretions, 
shed their tails, and immediately metamorphose into schisto-
somula (Fig 1). Only 20 to 60% of these survive into adulthood; 
most die in the skin. The surviving young worms migrate 
through the circulatory systems to the lungs, and pass to tbe 
portal venous system of the liver, where they mature, mate, and 
pass down into the mesenteric veins. Adult schistosome worms 
which do not replicate within the mammalian host live 5 to 10 
yr in man and at least 1 yr in the mouse. The various cellular 
and humoral immune responses to these stages of the parasite 
ICG ftIdIl& _.I\tII ....... ,....... .........  ....... 
"',c'=' r"" 
l~i \(::.;1 
I ; 
.. au.CIDII1W ....... _ 
........... 'IaI . ... I1 ..... 
..... _ ... .... .-, .. 
FIG 1. The life cycle of Schistosoma. (World Health Organization 
photo.) 
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life-cycle, although irritating, do not appear to cause severe 
pathologic damage. 
Five weeks after infection the female of each worm pair 
begins to produce 300 to 3,000 eggs daily. The inflammatory 
response to these eggs is the basis for the pathophysiological 
changes that occur in hepatosplenic schistosomal disease [2]. 
Enzymes and other materials, that facilitate egg passage out of 
the blood vessels through the tissues of the intestinal wall and 
into the lumen escape through small pores in the egg shell. 
When the eggs are passed out in the excreta they hatch into 
miracidia, and continue their life-cycle by infecting snails. Most 
of the eggs, however, are trapped in the liver and intestines, 
where they survive for 3 weeks. During the time within the 
tissues, the eggs continue to secrete antigenic material, called 
soluble egg antigen (SEA). There is a sequential host immune 
response to the SEA. Early after infection (7 to 10 weeks), eggs 
elicit a cell-mediated immune granulomatous reaction. 
In our current idea' of the mechanism of S . mansoni granu-
loma formation we divide this process into 4 stages. In the first 
stage SEA is slowly released from the 160 x 60 IJ. egg and 
induces sensitization of the cell-mediated immunity (eMI) sys-
tem. Next, the antigen reacts with the effector cells (sensitized 
T lymphocytes) and stimulates them to produce the lympho-
kine macrophage migration inhibitory factor (MIF) and eosin-
ophil stimulation promotor (ESP) (Fig 2A) . In the third stage, 
these lyrnphokines attract to the focus of antigenic stimulus 
macro phages and eosinophils, which when activated induce the 
granuloma. In the fourth stage (after 3 weeks), the embryo 
within the egg dies and the production of endogenous antigens 
declines. With the cessation of immunologic stimulation, heal-
ing and/or fibrosis occur. These granulomatous inflammatory 
lesions lead to fibrosis that causes obstruction to the portal 
blood flow through the liver with consequent hepatomegaly, 
splenomegaly, and esophageal varices. We have recently taken 
these studies on disease activation down to the molecular level 
by experiments on the in vitro synthesis of lymphokines by 
isolated cultured granulomas and by the identification, purifi-
cation, and characterization of the SEA [3,4]' 
• Pelley RP, Boros DL, Warren KS: Lyrnphokine production and 
protein synthesis by isolated, cultured schistosoma granulomas, to be \ 
published. 
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DISEASE SUPPRESSION 
The Phenomenon of Modulation 
The general dynamics of disease modulation are delineated 
in Fig 3. Humoral immunity (HI) increases with increasing time 
after infection, CMI declines, and pathophysiological changes 
decrease. 
The meaning of modulation can be appreciated by the im-
provement that takes place in the clinical condition of lightly 
infected mice 8 to 10 weeks after infection. After about 16 
weeks, portal pressure, splenomegaly, hepatomegaly, and inci-
dences of esophageal varices begin to decline in parallel. Serum 
lysozyme levels (a quantitative measure of inflammatory activ-
ity) and incidences of specific mortality return to normal (Fig . 
3) after modulation is complete. As the disease improves gran-
ulomatous hypersensitivity decreases. Granulomas can be m ea-
sured most precisely by intravenous injection of eggs into mice 
at various times after infection. These eggs become lodged in 
the pulmonary arterioles and lesions develop around them. The 
area of inflammation around the eggs can be quantified in 
histological sections with a semiautomated Millipore 7TMC par-
ticle-measuring microprocessor . S. mansoni worms do not nor-
mally lay eggs in the lungs, and measurement of inflammation 
is not complicated by old fibrotic lesions, as it is with measure-
ments of liver granulomas. Inflammation is maximal eight 
weeks after infection (Fig 3) . The size of granulomas wanes 16 
weeks after infection and reaches a minimum after 20 weeks. In 
animals with modulated granulomas the lesions are actually 
smaller than in normal, unsensitized animals [10]. 
Humoral immune responses to S . mansoni egg antigens de-
velop more slowly than cellular immune responses. Small but 
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FIG 3. Immune responses in mice with c1u-onic S. mansoni infections. 
This figure summarizes our observations and data on the modulation 
of granulomatous hypersensitivity and correlates them wi th observa-
tions in other laboratories. Unless otherwise stated all data are from 
outbred Swiss mice subcutaneously infected with 10 cercariae of the 
Puerto Rican strain of S. mansoni by the method of Peters and Warren 
[5]. Morbidity: Serum lysozyme [6] probably reflects the release of 
lysozomal enzymes from the activated macrophages in granulomas. It 
reasonably reflects changes in hepatomegaly, splenomegaly, and portal 
hypertension [7]. Antibody: Antibody to egg antigens is measured by 
passive hemagglutination with crude SEA [8]. These data are similar 
to those obtained with the anti-MSA, radioimmunoassay, except that 
passive hemagglutination overemphasizes the IgM response occurring 
between 8 and 10 weeks. Similar results have been obtained by Colley 
[9] with inbred CBA mice and a slightly higher intensity of infection 
(30 cercariae). Cellular immunity: The data on pulmonary granuloma-
tous hypersensitivity and MIF production [8] al'e similar to those later 
published by Colley [9] on granuloma size in livers and production of 
the lymphokine ESP in inbred CBA mice infected with 30 cercal·iae. 
We observed that cutaneous delayed hypersensitivity pal'alleled gran-
ulomatous hypersensitivity and in vitro CM! [8]. 
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FIG 4. Inhibition of granulomatous hypersensitivity by murine 
chronic S. mansoni infection serum. Serum was obtained from normal 
outbred CFl mice, CF 1 mice 8 weeks after infection with 200 S. 
mansoni cercal'iae (acute infection serum) , or 34 weeks after infection 
with 10 S. mansoni cercariae (chronic infection serum). Patency of 
infection in last group was established by Ouchterlony immunodiffusion 
analysis of individual sera with SEA [14]. Mice received intraperitoneal 
injections of 1 ml of serum on day 0, day 6, and day 12 01' received no 
serum (control) . FoW' hoW's after the first serum injection all mice 
received an i.v. injection of 3,000 S. mansoni eggs. After 16 days the 
mice were killed, and the lungs were removed and processed for 
hematoxylin and eosin histological studies. The area of inflammation 
around the eggs (minus the area of the egg itself) was measW'ed in a 
Millipore '1TMC particle measuring system. At least 25 lesions were 
measW'ed in each animal, and statistical significance assessed by stu-
dent's t-test as previously described [4]. 
significant amounts of IgM antiegg antibody can be detected 6 
and 7 weeks after infection (1 to 2 weeks after egg laying begins) 
by a highly sensitive radioimmunoassay for a major granuloma 
antigen (major serological antigen #1; MSA,). Passive hemag-
glutination with SEA-coated sheep erythrocytes detects antiegg 
antibody 8 weeks after infection when the purified-egg-antigen 
radioimmunoassay shows the humoral immune response to be 
50 to 65% IgM. There is a 4 to 6 weeks IgM/ IgG switchover 
period, and 16 weeks after infection the response is completely 
IgG. Precipitating antibody to MSA, is first seen 10 weeks after 
infection, and in the next few weeks the precipitin levels rise 
rapidly. This steady rise in the absolute quantity of anti-MSA, 
antibody is concomitant with a progressive increase in the 
relative antibody affinity. At 7 to 8 weeks the relative affinity 
is 32 to 38t; by 10 to 12 weeks, it reach es 48 to 52. By the time 
modulation is complete, 8 to 20 weeks after infection, th ere is 
a polyclonal increase in total serum IgG from 5 mg/ ml of IgG 
to 20 mg/ ml. Thus, in lightly infected outbred mice, hypersen-
sitivity disease is apparently modulated through an inhibition 
of the CM! and an increase in the HI, with a gradual improve-
ment in the disease state. 
Some of the features mentioned above are also discerned in 
human schistosomiasis [11 ,12]. During early human schistoso-
t We arrived at the relative affini ty by determining antigen binding 
at a number of antibody concentrations and obtaining slope by curve 
fitting. A slope coefficient of 50 indicates an essentially il'feversible 
reaction due to high-affinity antibody. 
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miasis, large granulomas have been found around the eggs in 
the submucosa of rectal tissue. Infected patients have low levels 
of antibody to the major granuloma antigen (MSA I ). Patients 
with chronic, modulated schistosomiasis have smaller granu-
lomas in their tissues and thei.r sera contain high levels of anti-
MSA I antibody. More than 95% of this antibody activity is in 
the IgG fraction of the serum (determined by ion-exchange 
chromatography on DEAE-cellulose). 
One Possible Disease Suppression Mechanism: Antibody 
Blockade 
In terms of modulation in schistosomiasis, outbred mice and 
man are in good agreement. With time, antibody rises and CMI 
declines. This can be explained by an elementary blockade 
theory (Fig 2B) . If enough antibody is produced, it binds all 
available antigen before the antigen can reach the T lympho-
cyte CMI effector cells. This assumption is consistent with the 
Hoeppli phenomenon: eosinophilic material is deposited around 
eggs in the tissues in chronic schistosomal infections. Von 
Lichtenberg has suggested that this material is egg antigen 
sequestered by.antibody in the immediate vicinity of the eggs 
[13]. 
The blockade hypothesis was directly tested in outbred mice 
in serum transfer experiments. Serum from clinically well, 
chronically infected mice was injected into normal recipient 
mice, which were then challenged by i.v. injections of S. man-
soni eggs. The area of inflammation (primary granulomatous 
hypersensitivity) was measured 8 days later. Serum from nor-
mal mice had no effect on inflammation. Serum from very ill 
mice with acute schistosomiasis did not inhibit granuloma 
formation; however serum from chronically infected mice 
caused significant suppression (Fig 4). Colley et al examined 
lymphocyte function in patients with chronic schistosomiasis in 
vitro. When they added autologous patient serum (presumably 
containing blockading antibody) to cultures containing lympho-
cytes and egg antigen, the antigen-induced DNA synthesis was 
inhibited [15]. 
A number of other observations make us question this sim-
plistic theory. First, the amounts of serum required to achieve 
significant suppression in mice are massive, i.e., the total plasma 
volume must be replaced. Second, the degree of suppression of 
murine granulomatous hypersensitivity, although significant, is 
not overwhelming. Finally, it has not been possible to suppress 
granulomatous inflammation in natural murine schistosome 
infections with passively transferred serum [16]. The blockade 
phenomenon may operate as one mechanism for disease sup-
pression in mice, but we are uncertain of its magnitude in the 
disease balance equation. Therefore, we have explored the 
possibility that there may be such other factors as suppressor 
cells that assist in modulation. 
SUPPRESSOR CELLS: A SECOND DISEASE 
SUPPRESSION MECHANISM? 
Direct Demonstration of Suppressor Cells 
Suppressor cells have been shown to constitute a second 
major immunoregulatory system in mice. The idea that certain 
cells, upon activation, might "suppress" the immune response 
developed during the early 1970's. Early suppression was first 
shown when (a) injection of cells from a nonresponder animal 
into a normal animal resulted in "suppression" of the response 
in the recipient animal [17] or (b) the removal of a cell popu-
lation from a poorly responsive animal increased the response 
[18]. 
Rich and Pierce [19] and Dutton [20] tied these observations 
into a single theory: when one line of T lymphocytes is activated 
it inhibits (suppresses) the functioning of a second lymphocyte. 
If this system is operating in chronic schistosomiasis, the reac-
tion shown below may be occurring (Fig 2C). Colley [16] fll'st 
showed that some cells specifically suppress CMI in chronic 
murine schistosomiasis. He injected lymph node and spleen 
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cells from CBA mice with acute or chronic infections, 20 to 50 
X 106 intravenously into CBA mice that had been infected with 
S. mansoni 6 weeks earlier. The liver granulomas of the infected 
recipient mice were then measured 2 weeks later, at a time 
when granulomatous hypersensitivity normally would be max-
imal. They obtained the most pronounced reduction in granu-
loma size with spleen cells from chronically infected mice. We 
recently examined this effect with the less complicated primary 
pulmonary granuloma system [21]. We obtained spleen cells 
from Balblc mice lightly infected 30 weeks earlier, in which 
modulation had occurred. Varyi.ng numbers of cells were in-
jected intravenously into normal Balblc recipients just before 
the i.v. injection of S. mansoni eggs. The pulmonary granu-
lomatous inflammation was measured 8 days later. Low doses 
(2 x 106 ) of cells had no effect on inflammation (Fig 5). Inter-
mediate doses of cells (6 x 106) resulted in increased inflam-
mation. These findings indicate that memory cells for CMI 
were still present in the suppressed donor animals. Finally, 
transfer of large numbers of cells (20 x 106 ) inhibited the active 
transfer of CM!. These experiments indicate that suppressor 
cells for CMI are present in chronic schistosomiasis: (i) transfer 
of cells from a nonresponding animal to a responding animal 
inhibits the response in the recipient animal and (ii) removal of 
a suppressive cell (by dilution) from a nonresponsive population 
restores the response. However, this in vivo system cannot be 
used in man. In order to study suppressor cells in human 
disease, more indirect approaches must be employed. 
Lymphokines: Dose-Response Curves 
Lymphokines such as ESP and MIF are the putative media-
tors of CM!. These factors, produced by activated T effector 
cells, attract macro phages and eosinophils into the lesion and 
activate them. If blockade were the sole mechanism operating 
duri"ng modulation, lymphocytes, when removed from the 
antibody-rich environment of the chronically infected animal 
and cultured in vitro, should have responded normally to the 
appropriate antigen, but they did not (Fig 3). Eight weeks after 
infection (before modulation) splenic lymphocytes made large 
amounts of MIF when stimulated with egg antigen. During 
chronic, modulated schistosomiasis (20 weeks after infection) 
they failed to respond. These were in vitro experiments in 
which antigen was added to cells i.n an antibody-poor environ- \ 
ment; there was nothing to interfere with antigen getting to the 
cells. Therefore, the failure to respond must have been due to 
a lack of reactive cells (tolerance), or else something prevented 
effector cells from responding. Complete, clonal-elimination 
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tolerance is an unlikely mechanism because: (i) the humoral 
immune responses to the same granuloma-inducing antigens 
were strong (consistent with immune deviation or split toler-
ance) and (ii) cell transfer eXPElriments (just discussed above) 
demonstrated that T lymphocyte eMI effector cells were still 
present in animals evincing modulation. 
Evidence for an active suppressing process was found in 
experiments with dose-response cW"ves. Biological responses 
usually display a sigmoid dose-response relationship (Fig 6, 
top). The minimal optimal dose of antigen needed to stimulate 
a cell is a measW"e of the avidity of that cell for antigen. Another 
cell with a lower avidity for the reactive agent will generate a 
second cW"ve shifted to the right (Fig 6, bottom). These avidity 
differences are commonly observed with in vitro immune sys-
tems. We examined the avidity of the eMI system in chronic 
murine schistosomiasis by looking at the minimal optimal dose 
for MIF production by spleen cells at various times after 
infection [8]. There was a progressive increase in avidity with 
time: the amount of antigen required for significant MIF pro-
duction became progressively lower (8 weeks, minimal optimal 
dose 1.0 /lg of SEA; 12 weeks, 0.1 /lg; 16 weeks, 0.01 /lg). This 
result was not unexpected since the affinity of the humoral 
immune response was concomitantly increasing. 
Lymphokines and Suppressor Cells 
We will now examine oW" theoretical model of 2 cells of 
differing avidity to see what would happen if the second cell 
(the one with the lower avidity) were responding to antigen by 
producing a factor that prevented the high-avidity cell from 
producing lymphokine. This situation would generate the hy-
pothetical curve shown in Fig 7, which resembles what we 
observed with spleen cells of 8-week S. mansoni infected mice 
[8]. These data are consistent with the simple suppressor hy-
pothesis outlined at the beginning of this section. In addition to 
stimulating T effector cells for eMI, SEA also activated a 
second, inhibitory cell with a lower avidity for antigen. When 
this second (suppressor) cell was stimulated by a high dose of 
antigen, it tW"ned off the MIF-producing lymphocytes. The 
result was inhibiti~n of MIF production by supraoptimal con-
centrations of antigen. 
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Let us reexamine the dynamics of lymphokine production 
during chronic murine schistosomiasis in the light of oW" new 
knowledge about what dose-response cW"ves mean. As the 
immune response matures, there is increased avidity of the T 
lymphocyte eMI effector cells for SEA, and a concomitant 
increase in the avidity of the T suppressor cells for antigen. 
Therefore, supraoptimal antigen doses progressively inhibit 
more MIF production. We suspect that as long as the avidity of 
effector cells for eMI stays ahead of the T suppressor cell 
avidity there will be some granulomatous reactivity in vivo. At 
20 weeks after infection, the number and avidity of the sup-
pressor T cells is great enough for them to completely suppress 
the activity of the lymphokine-producing T effector cells for 
CML This supposition was recently examined by Boros. He 
was able to show that addition of spleen cells from chronically 
infected mice to 8-week spleen cells completely inhibits MIF 
production·t 
Suppression of the Response to Mitogens: What Does DNA 
Synthesis Mean? 
A second line of indirect evidence for the existence of sup-
pressor cells in chronic schistosomiasis comes from experiments 
on lymphocyte mitogenesis. Lymphocyte DNA synthesis, In-
duced by either antigen or mitogen, has become the most 
frequently used human in vitro correlate of delayed hypersen-
sitivity. Data obtained from this system must be interpreted 
with caution. DNA synthesis by itself does not represent the 
production of biologically significant inflammatory activity (or 
macrophage/ eosinophil activation) but rather only reflects 
stimulation of memory cells. The DNA is made during the 
recruitment of metabolically active effector cells from metabol-
ically quiescent memory cells (Fig 2D). It is the postmitotic 
effector cell that, upon stimulation, carries out the inflamma-
tory functions we normally associate with lymphocytes (lym-
phokine production, cell-mediated cytotoxicity, and macro-
phage/ eosinophil activation). Thus DNA synthesis itself does 
not represent delayed hypersensitivity j CMI but only a reaction 
preceding active CML 
When interpreting antigen-induced lymphocyte DNA syn-
thesis, the process illustrated above can occur in either B cells, 
T cells of the CMI system, or T helper cells for the humoral 
immune system. Thus, although antigen-induced DNA synthe-
sis was originally (and in some places still is) regarded as an in 
vitro correlate of CMI, it does not specifically measure effector 
function in CML 
Mitogen-induced DNA synthesis, on the other hand, can be 
specifically applied to either T or B cells by virtue of the 
specificity of phytohemagglutinin (PHA) and concanavalin A 
(Con A) for T cells and lipopolysaccharide for B cells. The 
utility of mitogens lies in their detection of nonspecific suppres-
sor cells, i.e., a suppressor cell that can be stimulated by one 
antigen and subsequently inhibit the response of another lym-
phocyte to a different antigen. Rich and Pierce [19] clearly and 
forcefully demonstrated that a "suppressor" cell can be acti-
vated by one agent (Con A) and inhibit the in vitro antibody 
response to an unrelated agent (sheep erythrocytes). Gershon, 
* DL Boros, personal communication. 
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Gery, and Waksman extended the utility of this observation by 
using the simple mitogen-induced DNA synthesis system as 
their detector system [22]. They found that when suppressor 
cells are activated by antigen, whether in vivo or in vitro, 
inhibition of mitogen-induced DNA synthesis results. This find-
ing has led to the widespread use of these heterologous assay 
systems to detect nonspecific suppressor cells according to the 
hypothesis given below (Fig 2E). In this theory, an antigen 
stimulates its antigen-specific T suppressor cell to produce a 
negative immunoregulatory factor that inhibits DNA synthesis 
in almost any T cell. This inhibition takes place irrespective of 
the antigen specificity of the T memory cell. Waksman's group 
has extensively characterized this factor and the mechanisms 
by which it exerts its effect; they have termed it inhibitor of 
DNA synthesis [23]. 
Nonspecific Suppressor Cells in Chronic Schistosomiasis 
Outbred mice with early (6 to 8 weeks postinfection) schis-
tosomiasis have a 50% depression of their response to the T cell 
mitogens Con A and PHA [24]. This depression is accompanied 
by a shift in the mitogen dose-response curve similar to that 
observed by Bash and Waksman [25] in their studies on the 
suppression induced in rats by simple proteins. During acute 
schistosomiasis Pellegrino et al found a depression of the anti-
body response to the T cell antigen sheep erythrocytes [26]. 
Severe, nonspecific, immunodepression occurs during chronic 
schistosomiasis in outbred mice. Between 12 and 20 weeks 
postinfection, T cell mitogen-induced DNA synthesis was de-
pressed by 90% or more [24]. A similar effect occurs in mice 
infected with the related parasite Schistosoma japonicum 
[27]. Late after chronic infection by schistosomes a variable and 
inconsistent recovery of DNA synthesis was observed. Coulis, 
Lewert, and Fitch [28] analyzed in vitro details of this nonspe-
cific suppression in schistosomiasis. They studied the effect of 
spleen cells from mice with S. mansoni infections upon the 
primary in vitro immune response of normal spleen cells to 
histocompatability antigens (allogeneic cells). Addition of 
spleen cells from infected animals inhibited the CM! response 
of normal cells. This suppression may be mediated by T lym-
phocytes or macrophages. 
These experiments have allowed us to formulate the hypoth-
esis elucidated below (Fig 2F). During modulation of the im-
mune response to schistosome antigens, a wide variety of het-
erologous cellular and humoral immune responses are sup-
pressed. These include DNA synthesis induced by mitogens, 
the antibody response to sheep erythrocytes, and the cellular 
immune response to allogeneic cells. Because many of these 
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responses can be studied in vitro, we now have a way with 
which to study nonspecific suppressor cells in human schisto-
somiasis. 
CONCLUSIONS 
Schistosomiasis is an immunologic disease, both in induction 
and controL We hypothesize that the induction of the disease 
depends on the balance between disease-activating processes 
and disease-suppressing processes (Fig 8) . In mice the major 
disease-producing process is granuloma formation, a CMI re-
action to the SEA. However, there are many possible ways for 
the host to suppress granulomatous hypersensitivity. Recent 
work in murine. systems has supplied us with 3 experimental 
systems: (1) accurate radioimmunoassays with which to quan-
tify antibody to the major granuloma-inducing antigens and 
thereby to study blockade, (2) lymphokine assays with which 
to measure specific suppressor cells, and (3) mitogen-induced 
DNA synthesis assays with which to study nonspecific suppres-
sor cells. 
We believe that disease induction and suppression interact in 
the following way. Before modulation sets in (7 to 9 weeks 
postinfection in the mouse), disease activation is dominant. 
However, even in this early stage we can detect that some 
disease-suppressing processes are beginning to emerge [16,24]' 
Later, when disease-activating processes are equal to disease-
suppressing ones, minimal disease is seen. Most patients with 
chronic schistosomiasis mansoni are seen at the balance point, 
i.e., when the 2 processes are equaL If modulation fails to occur, 
disease predominates. If disease suppression becomes over-
whelming, anergy is observed. 
The task that remains is to find which of the 3 possible 
disease-suppressing processes predominates in man. All 3 of the 
tools .outlined above can be used; we now need to discern which 
is lacl~ing when modulation fails and disease dominates. 
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